183 related articles for article (PubMed ID: 29143288)
1. GSK3β Controls mTOR and Prosurvival Signaling in Neurons.
Urbanska M; Gozdz A; Macias M; Cymerman IA; Liszewska E; Kondratiuk I; Devijver H; Lechat B; Van Leuven F; Jaworski J
Mol Neurobiol; 2018 Jul; 55(7):6050-6062. PubMed ID: 29143288
[TBL] [Abstract][Full Text] [Related]
2. Akt and mTOR mediate programmed necrosis in neurons.
Liu Q; Qiu J; Liang M; Golinski J; van Leyen K; Jung JE; You Z; Lo EH; Degterev A; Whalen MJ
Cell Death Dis; 2014 Feb; 5(2):e1084. PubMed ID: 24577082
[TBL] [Abstract][Full Text] [Related]
3. Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein.
Case N; Thomas J; Sen B; Styner M; Xie Z; Galior K; Rubin J
J Biol Chem; 2011 Nov; 286(45):39450-6. PubMed ID: 21956113
[TBL] [Abstract][Full Text] [Related]
4. GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation.
Urbanska M; Kazmierska-Grebowska P; Kowalczyk T; Caban B; Nader K; Pijet B; Kalita K; Gozdz A; Devijver H; Lechat B; Jaworski T; Grajkowska W; Sadowski K; Jozwiak S; Kotulska K; Konopacki J; Van Leuven F; van Vliet EA; Aronica E; Jaworski J
EBioMedicine; 2019 Jan; 39():377-387. PubMed ID: 30502054
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system.
Miao L; Yang L; Huang H; Liang F; Ling C; Hu Y
Elife; 2016 Mar; 5():e14908. PubMed ID: 27026523
[TBL] [Abstract][Full Text] [Related]
6. Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival.
Swiatkowski P; Nikolaeva I; Kumar G; Zucco A; Akum BF; Patel MV; D'Arcangelo G; Firestein BL
Sci Rep; 2017 May; 7(1):1539. PubMed ID: 28484273
[TBL] [Abstract][Full Text] [Related]
7. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
9. Lithium protects against methamphetamine-induced neurotoxicity in PC12 cells via Akt/GSK3β/mTOR pathway.
Wu J; Zhu D; Zhang J; Li G; Liu Z; Sun J
Biochem Biophys Res Commun; 2015 Sep; 465(3):368-73. PubMed ID: 26271595
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats.
Endo H; Nito C; Kamada H; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2006 Dec; 26(12):1479-89. PubMed ID: 16538228
[TBL] [Abstract][Full Text] [Related]
11. LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling.
Qiu YS; Jiang NN; Zhou Y; Yu KY; Gong HY; Liao GJ
Int J Mol Med; 2018 May; 41(5):2755-2763. PubMed ID: 29436606
[TBL] [Abstract][Full Text] [Related]
12. Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance.
Chang H; Di T; Wang Y; Zeng X; Li G; Wan Q; Yu W; Chen L
Neurobiol Dis; 2019 Jul; 127():350-361. PubMed ID: 30910747
[TBL] [Abstract][Full Text] [Related]
13. Echinacoside, an Active Constituent of Cistanche Herba, Exerts a Neuroprotective Effect in a Kainic Acid Rat Model by Inhibiting Inflammatory Processes and Activating the Akt/GSK3β Pathway.
Lu CW; Hsieh HL; Lin TY; Hsieh TY; Huang SK; Wang SJ
Biol Pharm Bull; 2018 Nov; 41(11):1685-1693. PubMed ID: 30197410
[TBL] [Abstract][Full Text] [Related]
14. Pathologic significance of AKT, mTOR, and GSK3β proteins in oral squamous cell carcinoma-affected patients.
Matsuo FS; Andrade MF; Loyola AM; da Silva SJ; Silva MJB; Cardoso SV; de Faria PR
Virchows Arch; 2018 Jun; 472(6):983-997. PubMed ID: 29713826
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
16. Excitotoxic glutamate causes neuronal insulin resistance by inhibiting insulin receptor/Akt/mTOR pathway.
Pomytkin I; Krasil'nikova I; Bakaeva Z; Surin A; Pinelis V
Mol Brain; 2019 Dec; 12(1):112. PubMed ID: 31856878
[TBL] [Abstract][Full Text] [Related]
17. Akt/GSK3beta survival signaling is involved in acute brain injury after subarachnoid hemorrhage in rats.
Endo H; Nito C; Kamada H; Yu F; Chan PH
Stroke; 2006 Aug; 37(8):2140-6. PubMed ID: 16794215
[TBL] [Abstract][Full Text] [Related]
18. Lithium Inhibits GSK3β Activity via Two Different Signaling Pathways in Neurons After Spinal Cord Injury.
Li B; Ren J; Yang L; Li X; Sun G; Xia M
Neurochem Res; 2018 Apr; 43(4):848-856. PubMed ID: 29404840
[TBL] [Abstract][Full Text] [Related]
19. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
[TBL] [Abstract][Full Text] [Related]
20. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
Lee CJ; Jang JH; Lee JY; Lee MH; Li Y; Ryu HW; Choi KI; Dong Z; Lee HS; Oh SR; Surh YJ; Cho YY
Carcinogenesis; 2015 Oct; 36(10):1223-34. PubMed ID: 26243309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
